Characterization of the binding site for cyclothialidine on the B subunit of DNA gyrase - PubMed (original) (raw)
. 1995 Jun 16;270(24):14286-91.
doi: 10.1074/jbc.270.24.14286.
Affiliations
- PMID: 7782285
- DOI: 10.1074/jbc.270.24.14286
Free article
Characterization of the binding site for cyclothialidine on the B subunit of DNA gyrase
N Nakada et al. J Biol Chem. 1995.
Free article
Abstract
The mechanism of inhibition of DNA gyrase by cyclothialidine, a novel gyrase inhibitor isolated from Streptomyces filipinensis NR0484, has been studied further by using [14C]benzoylcyclothialidine and a reconstituted Escherichia coli gyrase system consisting of the A subunit, the B subunit and relaxed ColE1 DNA. The mechanism of inhibition was also studied with the 43-kDa N-terminal fragment of the B subunit. The [14C]benzoylcyclothialidine could bind to the B subunit alone but not to the A subunit nor to the plasmid DNA alone. Furthermore, the compound also bound to the 43-kDa N-terminal fragment of the B subunit. Scatchard analysis of [14C]benzoylcyclothialidine binding to DNA gyrase showed that the binding affinity of the compound increased, depending on the assembly of the gyrase (A2B2). DNA complex. This suggests that the binding site of cyclothialidine on the B subunit or its vicinity causes a conformational change during the assembly of the gyrase.DNA complex (increase in affinity: B-->A2B2-->A2B2.DNA). Furthermore, displacement curves of [14C]benzoylcyclothialidine binding by nonlabeled cyclothialidine, ATP analogues, and coumarin antibiotics indicated that cyclothialidine, coumarins, and ATP share a common (or overlapping) site of action on the B subunit of DNA gyrase; however, the microenvironment of the binding sites may differ.
Similar articles
- GyrB mutations in Staphylococcus aureus strains resistant to cyclothialidine, coumermycin, and novobiocin.
Stieger M, Angehrn P, Wohlgensinger B, Gmünder H. Stieger M, et al. Antimicrob Agents Chemother. 1996 Apr;40(4):1060-2. doi: 10.1128/AAC.40.4.1060. Antimicrob Agents Chemother. 1996. PMID: 8849232 Free PMC article. - Mechanism of inhibition of DNA gyrase by cyclothialidine, a novel DNA gyrase inhibitor.
Nakada N, Gmünder H, Hirata T, Arisawa M. Nakada N, et al. Antimicrob Agents Chemother. 1994 Sep;38(9):1966-73. doi: 10.1128/AAC.38.9.1966. Antimicrob Agents Chemother. 1994. PMID: 7811004 Free PMC article. - The interaction between coumarin drugs and DNA gyrase.
Maxwell A. Maxwell A. Mol Microbiol. 1993 Aug;9(4):681-6. doi: 10.1111/j.1365-2958.1993.tb01728.x. Mol Microbiol. 1993. PMID: 8231802 Review. - The high-resolution crystal structure of a 24-kDa gyrase B fragment from E. coli complexed with one of the most potent coumarin inhibitors, clorobiocin.
Tsai FT, Singh OM, Skarzynski T, Wonacott AJ, Weston S, Tucker A, Pauptit RA, Breeze AL, Poyser JP, O'Brien R, Ladbury JE, Wigley DB. Tsai FT, et al. Proteins. 1997 May;28(1):41-52. Proteins. 1997. PMID: 9144789 - DNA gyrase and the supercoiling of DNA.
Cozzarelli NR. Cozzarelli NR. Science. 1980 Feb 29;207(4434):953-60. doi: 10.1126/science.6243420. Science. 1980. PMID: 6243420 Review.
Cited by
- A high-throughput fluorescence polarization assay for inhibitors of gyrase B.
Glaser BT, Malerich JP, Duellman SJ, Fong J, Hutson C, Fine RM, Keblansky B, Tang MJ, Madrid PB. Glaser BT, et al. J Biomol Screen. 2011 Feb;16(2):230-8. doi: 10.1177/1087057110392038. Epub 2011 Jan 18. J Biomol Screen. 2011. PMID: 21245469 Free PMC article. - Identification of an auxiliary druggable pocket in the DNA gyrase ATPase domain using fragment probes.
Huang X, Guo J, Liu Q, Gu Q, Xu J, Zhou H. Huang X, et al. Medchemcomm. 2018 Jul 4;9(10):1619-1629. doi: 10.1039/c8md00148k. eCollection 2018 Oct 1. Medchemcomm. 2018. PMID: 30429968 Free PMC article. - Gene expression changes triggered by exposure of Haemophilus influenzae to novobiocin or ciprofloxacin: combined transcription and translation analysis.
Gmuender H, Kuratli K, Di Padova K, Gray CP, Keck W, Evers S. Gmuender H, et al. Genome Res. 2001 Jan;11(1):28-42. doi: 10.1101/gr.157701. Genome Res. 2001. PMID: 11156613 Free PMC article. - GyrB mutations in Staphylococcus aureus strains resistant to cyclothialidine, coumermycin, and novobiocin.
Stieger M, Angehrn P, Wohlgensinger B, Gmünder H. Stieger M, et al. Antimicrob Agents Chemother. 1996 Apr;40(4):1060-2. doi: 10.1128/AAC.40.4.1060. Antimicrob Agents Chemother. 1996. PMID: 8849232 Free PMC article. - Exploiting bacterial DNA gyrase as a drug target: current state and perspectives.
Collin F, Karkare S, Maxwell A. Collin F, et al. Appl Microbiol Biotechnol. 2011 Nov;92(3):479-97. doi: 10.1007/s00253-011-3557-z. Epub 2011 Sep 9. Appl Microbiol Biotechnol. 2011. PMID: 21904817 Free PMC article. Review.